Literature DB >> 25461474

The association of uncontrolled HIV infection and other sexually transmitted infections in metropolitan Atlanta youth.

Pamela S Brownstein1, Scott E Gillespie, Traci Leong, Ann Chahroudi, Rana Chakraborty, Andres F Camacho-Gonzalez.   

Abstract

BACKGROUND: Half of the 19 million sexually transmitted infections (STIs) and 26% of HIV infections annually in the United States occur in youth aged 13-24 years. STIs are a risk factor for HIV acquisition and transmission, but data are lacking on HIV treatment as an intervention to reduce STIs.
METHODS: A single-centered, retrospective analysis of HIV-infected sexually active adolescents and young adults from January 2009 to December 2011 was performed to compare STI incidence among patients with controlled and uncontrolled HIV and to identify associated risk factors.
RESULTS: Of 205 enrolled subjects, 59% were male and 92% African American with mean age of 21 years (2.1 SD). Sixty-six percent were horizontally infected, and 19% met the definition of controlled HIV. Forty-seven percent were men who have sex with men, 76% reported condom use, 27% prior sexual abuse, 58% drug use and 50% claimed >5 lifetime sexual partners. Sixty-seven percent contracted a co-STI for a cumulative incidence rate of 35 STIs per 100 person-years. Subjects with uncontrolled HIV had a significantly higher STI incidence than did subjects with controlled infection (42.7 vs. 19.7 per 100 person-years, P < 0.001). Uncontrolled individuals had more STIs (P = 0.01), sexual partners (P = 0.008) and horizontal acquisition (P = 0.001). In an adjusted logistic model, having ≥1 STI was associated with older age (P = 0.033), >5 sexual partners (6-10 partners, P = 0.001; >10, P < 0.001) and no condom use (P = 0.025). Subjects with uncontrolled infection had 2.8 times [95% confidence interval (CI): 1.16-6.94] the odds of ≥1 STI relative to controlled HIV.
CONCLUSIONS: Uncontrolled HIV increases the incidence of co-STIs among adolescents and young adults. Interventions to improve antiretroviral compliance and reduce risk behaviors are urgently needed.

Entities:  

Mesh:

Year:  2015        PMID: 25461474     DOI: 10.1097/INF.0000000000000632

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  5 in total

1.  Association of Risk of Viremia, Immunosuppression, Serious Clinical Events, and Mortality With Increasing Age in Perinatally Human Immunodeficiency Virus-Infected Youth.

Authors:  Anne M Neilan; Brad Karalius; Kunjal Patel; Russell B Van Dyke; Mark J Abzug; Allison L Agwu; Paige L Williams; Murli Purswani; Deborah Kacanek; James M Oleske; Sandra K Burchett; Andrew Wiznia; Miriam Chernoff; George R Seage; Andrea L Ciaranello
Journal:  JAMA Pediatr       Date:  2017-05-01       Impact factor: 16.193

2.  The Prevalence of Human Immunodeficiency Virus Infection in Patients with Sexually Transmitted Diseases.

Authors:  Mohammad Mahdi Majzoobi; Mohammad Reza Sobhan; Mehrangiz Zamani; Abbas Moradi; Sahar Khosravi; Ali Saadatmand
Journal:  Adv Biomed Res       Date:  2020-03-16

3.  Rates of Sexually Transmitted Infection Diagnoses Among US Youth With Perinatally and Nonperinatally Acquired HIV.

Authors:  Anne M Neilan; Justin B DeMonte; Julia H A Foote; Brad Karalius; Kunjal Patel; Bill G Kapogiannis; Bret J Rudy; Heather Huszti; M Isabel Fernandez; Michael G Hudgens; Andrea L Ciaranello
Journal:  Sex Transm Dis       Date:  2022-03-01       Impact factor: 3.868

4.  Sexually Transmitted Infections in Youth With Controlled and Uncontrolled Human Immunodeficiency Virus Infection.

Authors:  Andres F Camacho-Gonzalez; Miriam C Chernoff; Paige L Williams; Ann Chahroudi; James M Oleske; Shirley Traite; Rana Chakraborty; Murli U Purswani; Mark J Abzug
Journal:  J Pediatric Infect Dis Soc       Date:  2017-09-01       Impact factor: 3.164

5.  Sexually transmitted infections and use of contraceptives in women living with HIV in Denmark - the SHADE cohort.

Authors:  Kristina Thorsteinsson; Steen Ladelund; Merete Storgaard; Frederikke Falkencrone Rønsholt; Isik Somuncu Johansen; Gitte Pedersen; Lars Nørregård Nielsen; Jesper Bonde; Henrik Westh; Niels Obel; Terese L Katzenstein; Anne-Mette Lebech
Journal:  BMC Infect Dis       Date:  2016-02-16       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.